Cecilia Marie Edström
Director/Board Member bij NEONODE INC.
Vermogen: 6 000 $ op 29-02-2024
Profiel
Cecilia Marie Edström is on the board of Neonode, Inc., BioArctic AB and A3P Biomedical AB.
In her past career she occupied the position of Chief Executive Officer & Director at Bactiguard Holding AB and Director at Bactiguard AB (a subsidiary of Bactiguard Holding AB), Senior Vice President & Head-Group Communications at Telia Co. AB, Senior Vice President-Corporate Relations at Scania AB and Member-Governing Council at Stockholm Chamber of Commerce.
She received an undergraduate degree from Stockholm School of Economics.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NEONODE INC.
0.03% | 18-04-2023 | 4 000 ( 0.03% ) | 6 000 $ | 29-02-2024 |
Actieve functies van Cecilia Marie Edström
Bedrijven | Functie | Begin |
---|---|---|
NEONODE INC. | Director/Board Member | 16-05-2022 |
BIOARCTIC AB | Director/Board Member | 01-06-2023 |
A3P Biomedical AB
A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Director/Board Member | - |
Eerdere bekende functies van Cecilia Marie Edström
Bedrijven | Functie | Einde |
---|---|---|
BACTIGUARD HOLDING AB | Chief Executive Officer | 01-10-2021 |
Nordic Public Affairs AB
Nordic Public Affairs AB Miscellaneous Commercial ServicesCommercial Services Nordic Public Affairs AB provides designs and implements public relations campaigns. The company was founded by Martina Lind and Johan Jakobsson and is headquartered in Stockholm, Sweden. | Director/Board Member | 01-05-2020 |
MEGAFON | Director/Board Member | 01-09-2013 |
TELIA COMPANY AB | Public Communications Contact | 01-08-2013 |
BE GROUP AB | Director/Board Member | 26-04-2013 |
Opleiding van Cecilia Marie Edström
Stockholm School of Economics | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
TELIA COMPANY AB | Communications |
BE GROUP AB | Distribution Services |
BIOARCTIC AB | Health Technology |
BACTIGUARD HOLDING AB | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Scania AB
Scania AB Motor VehiclesConsumer Durables SCANIA AB engages in the manufacture of commercial vehicles, which include heavy trucks and buses, as well as diesel engines and general industrial appliances. It operates through the Vehicles and Services and Financial Services segments. The Vehicles and Services segment encompasses trucks, buses and engines, including the services associated with these products. The Financial Services segment offers financial solutions such as loan financing, lease contracts, and insurance solutions. The company was founded in 1891 and is headquartered in Sodertalje, Sweden. | Consumer Durables |
MegaFon PJSC
MegaFon PJSC Wireless TelecommunicationsCommunications MegaFon PJSC engages in the provision of telecommunications services. It offers voice, mobile and fixed-line data transfer, wireless data and wireless broadband services, roaming, short message service, and value-added service, developing business solutions, and sales of mobile phones and other electronics. The company was founded on June 17, 1993 and is headquartered in Moscow, Russia. | Communications |
Bactiguard AB
Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Distribution Services |
Neonode, Inc. | |
Stockholm Chamber of Commerce
Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Commercial Services |
Nordic Public Affairs AB
Nordic Public Affairs AB Miscellaneous Commercial ServicesCommercial Services Nordic Public Affairs AB provides designs and implements public relations campaigns. The company was founded by Martina Lind and Johan Jakobsson and is headquartered in Stockholm, Sweden. | Commercial Services |
A3P Biomedical AB
A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Health Services |